DJ AbbVie Inc. Stock Underperforms Monday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of AbbVie Inc. $(ABBV)$ slipped 1.64% to $170.16 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 2.36% to 5,158.20 and Dow Jones Industrial Average falling 2.48% to 38,170.41.
AbbVie Inc. closed 22.18% short of its 52-week high of $218.66, which the company reached on March 10th.
The stock underperformed when compared to some of its competitors Monday, as Johnson & Johnson $(JNJ)$ fell 0.35% to $156.92, Pfizer Inc. $(PFE)$ fell 0.45% to $22.04, and Amgen Inc. $(AMGN)$ fell 1.30% to $273.68.
Trading volume (7.2 M) remained 270,049 below its 50-day average volume of 7.5 M.
Data source: Dow Jones Market Data, FactSet. Data compiled April 21, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
April 21, 2025 16:32 ET (20:32 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。